ClearPoint Neuro Inc (CLPT)
10.93
-0.31
(-2.76%)
USD |
NASDAQ |
Nov 15, 16:00
10.94
+0.01
(+0.09%)
After-Hours: 20:00
ClearPoint Neuro Research and Development Expense (TTM): 11.71M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 11.71M |
| June 30, 2024 | 10.83M |
| March 31, 2024 | 11.31M |
| December 31, 2023 | 11.71M |
| September 30, 2023 | 11.98M |
| June 30, 2023 | 12.21M |
| March 31, 2023 | 11.02M |
| December 31, 2022 | 10.89M |
| September 30, 2022 | 11.04M |
| June 30, 2022 | 10.99M |
| March 31, 2022 | 10.68M |
| December 31, 2021 | 9.346M |
| September 30, 2021 | 8.185M |
| June 30, 2021 | 6.727M |
| March 31, 2021 | 5.43M |
| December 31, 2020 | 4.685M |
| September 30, 2020 | 3.539M |
| June 30, 2020 | 3.158M |
| March 31, 2020 | 3.044M |
| December 31, 2019 | 2.81M |
| September 30, 2019 | 2.526M |
| June 30, 2019 | 2.381M |
| March 31, 2019 | 2.348M |
| December 31, 2018 | 2.310M |
| September 30, 2018 | 2.411M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.384M |
| March 31, 2018 | 2.802M |
| December 31, 2017 | 2.814M |
| September 30, 2017 | 2.761M |
| June 30, 2017 | 2.863M |
| March 31, 2017 | 2.529M |
| December 31, 2016 | 2.628M |
| September 30, 2016 | 2.621M |
| June 30, 2016 | 2.41M |
| March 31, 2016 | 2.087M |
| December 31, 2015 | 1.957M |
| September 30, 2015 | 2.142M |
| June 30, 2015 | 2.536M |
| March 31, 2015 | 3.007M |
| December 31, 2014 | 3.297M |
| September 30, 2014 | 3.274M |
| June 30, 2014 | 3.126M |
| March 31, 2014 | 2.969M |
| December 31, 2013 | 2.923M |
| September 30, 2013 | 2.974M |
| June 30, 2013 | 2.822M |
| March 31, 2013 | 1.684M |
| December 31, 2012 | 1.602M |
| September 30, 2012 | 1.985M |
| June 30, 2012 | 2.321M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
2.81M
Minimum
Dec 2019
12.21M
Maximum
Jun 2023
8.565M
Average
10.76M
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |